GSK to acquire Aiolos Bio for US$ 1 billion upfront payment
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
The congress aims at emphasizing on the most recent trends, advancements in the field of Obstetrics & Gynaecology
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
Both the India and GCC entities will be operated by separate dedicated management teams
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
US business grew by +12.8% YoY
Eni will guarantee Dompé researchers access to its laboratories, support from the company's specialized staff, and use of its HPC5 supercomputer
Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
Subscribe To Our Newsletter & Stay Updated